Genzyme Recalls Mozobil Vials Due to Incorrect or Missing Lot and Expiration Dates
Genzyme is recalling 9,530 vials of Mozobil (plerixafor) because some have incorrect or missing lot and expiration dates.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences. The issue is a documentation/labeling defect (missing/incorrect dates) rather than a direct safety hazard like contamination or dosage error.
Plain-English summary
Genzyme Corporation is voluntarily recalling 9,530 vials of Mozobil (plerixafor) 24 mg/1.2 mL (20 mg/mL) for subcutaneous injection. The recall is due to a labeling defect where some vials have incorrect or missing lot and expiration dates.
The affected product is identified by Lot # 5RZ002 with an expiration date of 04/18. The vials were distributed nationwide. Mozobil is a prescription drug used to increase hematopoietic stem cell mobilization.
Healthcare providers and patients should stop using the affected vials and contact their healthcare provider or Genzyme for further instructions. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
The recalled product
- Product
- MOZOBIL (PLERIXAFOR)
- Brand
- MOZOBIL
- Manufacturer
- Genzyme Corporation / Genzyme Biosurgery
- Category
- Drug — Prescription Injection
- Hazard
- Affected units
- 9,530
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 5RZ002
- Exp. 04/18
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · MOZOBIL
- LowSanofi Recalls Mozobil Vials Due to Incorrect or Missing Package Insert
FDA (Drugs) · 2017-05-17
Same manufacturer · Genzyme Corporation / Genzyme Biosurgery
See all →- LowGenzyme Recalls Hectorol Injection Vials Due to Incorrect Barcode Labeling
FDA (Drugs) · 2016-06-22
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02